Privia Health Group Inc (OQ:PRVA)
Business Focus: Healthcare Facilities & Services
| Sector: Healthcare | Industry: Healthcare Facilities & Services |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 950 N. Glebe Rd., Suite 700 ARLINGTON VA 22203 |
| Tel: | N/A |
| Website: | https://www.priviahealth.com |
| IR: | See website |
| Key People | ||
| Parth Mehrotra Chief Executive Officer, Director | David Mountcastle Chief Financial Officer, Executive Vice President | Thomas Bartrum Executive Vice President, General Counsel |
| Business Overview |
| Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, develop patient experiences and doctors for delivering care in both in-person and virtual care settings. The Company's platform is purpose-built, organizing physicians into value-based and primary-care centric networks bolstered by physician governance, and promotes a culture of physician leadership. The Privia Platform is powered by the Company's proprietary end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services (the Privia Technology Solution). It provides management services to each Medical Group though a local management services organization. |
| Financial Overview |
| For the nine months ended 30 September 2023, Privia Health Group Inc revenues increased 23% to $1.22B. Net income totaled $20.2M vs. loss of $26.4M. Revenues reflect Capitated revenue segment increase of 58% to $253.5M, FFS-patient care segment increase of 10% to $704.3M. Net Income reflects Interest (income) expense, net increase from $285K to $5.5M (income). |
| Employees: | 964 as of Dec 31, 2022 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $2,109M as of Sep 30, 2023 |
| Annual revenue (TTM): | $1,581M as of Sep 30, 2023 |
| EBITDA (TTM): | $34.61M as of Sep 30, 2023 |
| Net annual income (TTM): | $38.02M as of Sep 30, 2023 |
| Free cash flow (TTM): | $45.73M as of Sep 30, 2023 |
| Net Debt Last Fiscal Year: | N/A |
| Shares outstanding: | 118,064,379 as of Oct 27, 2023 |
| Index Membership: | S&P 600 Small Cap |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2023 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.